Broad-Spectrum Antiviral Strategies Against Emerging and Re-Emerging Viral Diseases
This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Special Issue Information
Dear Colleagues,
The relentless emergence and re-emergence of viral pathogens pose a formidable challenge to global public health security. The rapid spread of novel viruses, coupled with the resurgence of previously controlled agents, underscores the critical need for proactive and adaptable countermeasures. Traditional pathogen-specific approaches often face delays in development and deployment, highlighting the urgency of broad-spectrum antiviral strategies. These strategies aim to target conserved viral elements or host cellular factors essential for the replication of diverse viral families, offering a promising avenue for rapid response against unpredictable outbreaks. This Special Issue of Viruses invites original research articles, comprehensive reviews, and insightful perspectives that explore innovative broad-spectrum antiviral approaches. We welcome contributions detailing the discovery and characterization of novel antiviral compounds, the elucidation of host–virus interactions amenable to broad-spectrum intervention, the development of host-directed therapies, and advancements in understanding viral resistance mechanisms. Submissions focusing on both preclinical and clinical advancements are encouraged, aiming to accelerate the translation of these vital strategies into tangible public health tools.
Prof. Dr. Yongtao Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- broad-spectrum antivirals
- emerging and re-emerging viruses
- host-directed therapies
- pan-viral inhibitors
- antiviral drug discovery
- host–virus interactions
- viral replication machinery
- pandemic preparedness
- drug repurposing
- viral pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

